Pediatric Fellows

Chair(s)

• 

  Felix Ratjen, MD (he/him/his)

  Pediatrics
  University of Toronto
• 

  Marie Egan, MD

  Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine
  Yale University School of Medicine

Facilitator(s)

• 

  Saharon Less Elazari, MD

  Schneider Children's Medical Center of Israel

This session is a series of selected 10- minute summaries of a patient case, clinical course & resolution followed by an interactive, moderated discussion of the lessons learned for pediatric CF care & providers.

Presentations:

• 7:45 AM – 9:45 AM ET

  PF1- Promoting Equity in Newborn Screening: Tackling Delayed Diagnosis of CF
  

  Speaker: Ashley L. Saint-Fleur, MD (she/her/hers) – Boston Children’s Hospital
• 7:45 AM – 9:45 AM ET

  PF2- Neuropsychiatric Side Effects Associated with CFTR Modulator Therapy in a Child, A Case Report
  

  Speaker: Agustin Cabrera, MD (he/him/his) – University of Miami
• 7:45 AM – 9:45 AM ET

  PF3- A Cholestatic Conundrum: Acute Cholestatic Hepatitis Following Initiation of CFTR Modulator Therapy in a Pediatric Patient
  

  Speaker: Audra Rougraff, MD (she/her/hers) – Indiana University School of Medicine
• 7:45 AM – 9:45 AM ET

  PF4- Prevention of Meconium Ileus in a Fetus with CF After Prenatal Use of Elexacaftor/Tezacaftor/Ivacaftor in a CF Carrier Mother
  

  Speaker: Angela Metcalf, MD (she/her/hers) – University of Colorado
• 7:45 AM – 9:45 AM ET

  PF5- When to Think Beyond Meconium Ileus?
  

  Speaker: Blanca I. Diaz Garcia, MD (she/her/hers) – University of Florida-Shands Children's Hospital
• 7:45 AM – 9:45 AM ET

  PF6- Community Acquired Clostridium Difficile Infection in a Toddler with CF
  

  Speaker: Allen Joe, MD (he/him/his) – UPMC Children's Hospital of Pittsburgh
• 7:45 AM – 9:45 AM ET

  PF7- Pneumonia, Bronchiectasis, & Staphylococcal Bacteremia in a Toddler with CF
  

  Speaker: Heba Ismael, MD (she/her/hers) – University of Iowa